Envestnet Asset Management
EDIT icon

Envestnet Asset Management’s Editas Medicine EDIT Stock Holding History

Envestnet Asset Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-72,942
Closed -$600K – 4051
2023
Q2 		$600K Buy
72,942
+18,346
+34% +$160K ﹤0.01% 3109
2023
Q1 		$396K Buy
54,596
+25,063
+85% +$223K ﹤0.01% 3297
2022
Q4 		$262K Sell
29,533
-1,872
-6% -$20.6K ﹤0.01% 3516
2022
Q3 		$384K Buy
31,405
+3,121
+11% +$48.6K ﹤0.01% 3200
2022
Q2 		$335K Buy
28,284
+4,223
+18% +$56.6K ﹤0.01% 3297
2022
Q1 		$458K Buy
24,061
+6,314
+36% +$117K ﹤0.01% 3163
2021
Q4 		$471K Sell
17,747
-4,518
-20% -$156K ﹤0.01% 3108
2021
Q3 		$915K Sell
22,265
-9,419
-30% -$516K ﹤0.01% 2608
2021
Q2 		$1.79M Buy
31,684
+4,295
+16% +$159K ﹤0.01% 2130
2021
Q1 		$1.15M Buy
27,389
+20,707
+310% +$1.18M ﹤0.01% 2299
2020
Q4 		$468K Buy
+6,682
New +$274K ﹤0.01% 2691

Other funds holding EDIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Envestnet Asset Management's EDIT Position: Q3 2023 in Review

Envestnet Asset Management sold out of Editas Medicine (EDIT) in Q3 2023, closing a stake of 72,942 shares — an estimated $600K sold.

Envestnet Asset Management first reported a position in EDIT in Q4 2020 and held it in 11 quarters. The position peaked at $1.79M in Q2 2021. 220 funds tracked by Wall St. Rank hold EDIT as of Q3 2023.

  • Envestnet Asset Management reported no remaining Editas Medicine position as of Q3 2023 after selling out during the quarter.
  • Envestnet Asset Management sold 72,942 Editas Medicine shares in Q3 2023, an estimated $600K.
  • Envestnet Asset Management first reported a position in Editas Medicine in Q4 2020 and held it in 11 quarters.
  • Envestnet Asset Management's Editas Medicine position peaked at $1.79M in Q2 2021.
  • 220 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2023.

Based on Envestnet Asset Management's 13F filing for Q3 2023, filed 13 Nov 2023.